COLLABORATION AGREEMENT BY AND BETWEEN MOMENTA PHARMACEUTICALS, INC. AND MYLAN IRELAND LIMITED, DATED AS OF JANUARY 8, 2016 Confidential Portions of this Exhibit marked as [***] have been omitted pursuant to a request for confidential treatment and...Collaboration Agreement • September 1st, 2016 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 1st, 2016 Company Industry JurisdictionThis Collaboration Agreement (the “Agreement”), executed as of January 8, 2016 (the “Execution Date”), is made by and between Momenta Pharmaceuticals, Inc., a Delaware corporation (“Momenta”), with a principal place of business at 675 West Kendall Street, Cambridge, Massachusetts 02142, and Mylan Ireland Limited, a limited company organized under the laws of Ireland (“Mylan”), with a principal place of business at South Bank House, Barrow Street, 6th Floor, Dublin 4, Ireland. Momenta and Mylan may each be referred to individually as a “Party” or, collectively, the “Parties”.